M. V. Astapova
Russian Academy of Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by M. V. Astapova.
Bioorganicheskaya Khimiya | 2000
I. A. Kostanyan; S. S. Zhokhov; M. V. Astapova; S. M. Dranitsyna; A. P. Bogachuk; L. K. Baidakova; Igor L. Rodionov; I. I. Baskin; O. N. Golubeva; Joyce Tombran-Tink; V. M. Lipkin
It was shown that the full-size neurotrophic factor from pigment epithelium (PEDF) induces the cell differentiation of the human promyelocyte leukemia cell line HL-60. A structural analysis of PEDF revealed in itsC-terminal region a six-membered peptide fragment PEDF-(352-357) (PEDF-6) whose sequence is highly homologous to the 41–46 fragment of the active site of the human leukocyte differentiation factor HLDF (HLDF-6). The biological effect of PEDF and synthetic peptides PEDF-6 and HLDF-6 on the HL-60 cells and the early gastrula ectoderm ofXenopus laevis embryos was studied. On the basis of the structural and functional homologies of HLDF, PEDF, and their homologous peptides and the computer models of the spatial structures of the full-size PEDF and the PEDF with theC-terminal fragment split off tby the cleavage of the Leu380-Thr381 bond in the serpin loop, a hypothesis on the functional role of the serpin loop in PEDF was put forward.
Bioorganicheskaia khimiia | 2002
S. M. Dranitsyna; I. A. Kostanyan; M. V. Astapova; E. A. Surina; V. M. Lipkin
The nuclease activity of human interleukin-10, an immunosuppressive cytokine, was predicted on the basis of structural homology between the 97–105 sequence of human interleukin-10 and the DNA/RNA-hydrolyzing fragment of the endogenous differentiation factor for the HL-60 line of human promyelocyte leukemia cells. The human recombinant interleukin-10 was shown to cleave all forms of plasmid DNA. The role of interleukin-10 in the apoptosis induction in monocytic cells was hypothesized.
Russian Journal of Bioorganic Chemistry | 2000
S. M. Dranitsyna; I. A. Kostanyan; S. G. Andreeva; M. V. Astapova; I. I. Babichenko; O. V. Baeva; Anna P. Bogachuk; I. M. Molotkovskaya; Igor L. Rodionov; E. V. Smirnova; V. M. Lipkin
A structural homology between the endogenous differentiation factor of the HL-60 cell line of promyelocyte leukemia (HLDF) and several DNA/RNA-binding and DNA/RNA-hydrolyzing proteins was revealed, and expression of thehldf gene in prokaryotic systems was studied. On the basis of these experiments, the amino acid sequence of an 8-membered fragment of HLDF with potential nuclease activity was identified. The synthetic octapeptide RRWHRLKE was shown to be capable of the cleavage of RNA, linear DNA from phage λ, and all forms of plasmid DNA. We established that treatment of the HL-60 cell culture with this peptide (10−6 M) results in an increase in the number of apoptotic cells and suggested that HLDF is involved in processes of apoptosis.
Russian Journal of Bioorganic Chemistry | 2004
E. V. Smirnova; A. V. Garkovenko; T. V. Rakitina; S. N. Berezhnoi; M. V. Astapova; E. A. Surina; I. I. Babichenko; I. A. Kostanyan; V. M. Lipkin
The mature differentiation factor HLDF, isolated from cultural medium, comprises 54 aa, whereas the open reading frame of mRNA encodes a 97-aa protein. We presumed that the protein translation begins from the first ATG codon, whose environment mostly meets the requirements for the initiation point. Two more ATG triplets are localized in positions 48–50 and 100–102 (numbering according to the structure of S21), i.e., in the area preceding the cDNA fragment that encodes the N-terminal fragment of the mature protein. The mRNAs of HLDF and S21 ribosomal protein have previously been shown to be highly homologous, and, therefore, their differences appear to be derived from two point deletions in the cDNA of the HLDF-encoding sequence (a G residue in position 112 and a C residue in position 224). As a result, the mature differentiation factor and RPS21 may be the products of translation from different open reading frames, the differentiation factor may be synthesized in the cell as a precursor, and its N-terminal sequence may be identical to that of RPS21. To test this hypothesis, we prepared recombinant RPS21 and the polyclonal antibodies to HLDF, full-size RPS21, and the C-terminal RPS21 peptide. Immunochemical staining by specially produced antibodies of native HL-60 cells and the same cells brought into apoptosis or differentiation confirmed that the precursor of the differentiation factor and the ribosomal S21 protein have a common N-terminal sequence and different cellular localizations. Neither an intron-containing gene nor a pseudogene with the nucleotide sequence corresponding to the HLDF cDNA was detected in the human genome or in the HL-60 cell line genome. On the basis of these facts, we propose a hypothesis of the molecular mechanism of the HLDF mRNA biosynthesis by means of posttranslational modifications of pre-mRNA of RPS21.
Russian Journal of Bioorganic Chemistry | 2003
R. V. Chertkova; I. A. Kostanyan; M. V. Astapova; E. A. Surina; D. A. Dolgikh; Kirpichnikov Mp
The ABB-df artificial protein was prepared by inserting the TGENHR biologically active peptide corresponding to the 41–46 sequence of the differentiation factor for the HL-60 cell line of the human promyelocyte leukemia into the N-terminus of the polypeptide chain of albebetin, an artificial protein with the preset structure. The ABB-df protein was found to induce the differentiation of HL-60 cells and to inhibit their proliferation; its efficiency was almost the same as that of the starting peptide. According to CD spectroscopy, the inclusion of the peptide fragment into albebetin exerts virtually no effect on the regular secondary structure of albebetin.
Russian Journal of Bioorganic Chemistry | 1998
I. A. Kostanyan; R. I. Nurieva; E. V. Navolotskaya; M. V. Astapova; S. M. Dranitsyna; V. P. Zav'yalov; V. M. Lipkin
Bioorganicheskaia khimiia | 2000
S. M. Dranitsyna; Kostanian Ia; Andreeva Sg; M. V. Astapova; Babichenko; Baeva Ov; Bogachuk Ap; Molotkovskaia Im; Rodionov Il; Smirnova Ev; V. M. Lipkin
Bioorganicheskaia khimiia | 1999
M. V. Astapova; V. M. Lipkin; Arkhipova Mv; Andreeva Sg; S. M. Dranitsyna; Merkulova Mi; R. I. Nurieva; Navolotskaia Ev; Kostanian Ia
Russian Journal of Bioorganic Chemistry | 1998
I. A. Kostanyan; R. I. Nurieva; T. N. Lepikhova; M. V. Astapova; E. V. Navolotskaya; V. P. Zav'yalov; V. M. Lipkin
Bioorganicheskaia khimiia | 1995
Kostanian Ia; M. V. Astapova; Starovoĭtova Ev; S. M. Dranitsyna; V. M. Lipkin